Panxiang Cao

477 citations
32 papers · 255 indexed · h-index 10
Topics
Acute Myeloid Leukemia Research (16 papers)Acute Lymphoblastic Leukemia research (12 papers)Chronic Myeloid Leukemia Treatments (10 papers)
Journals
SHILAP Revista de lepidopterologíaBloodCancer
Partner nations
ChinaUnited States

In The Last Decade

Panxiang Cao

29 papers receiving 248 citations

Peers

Panxiang Cao
Comparison fields: 5 of 42
  • Hematology 160
  • Molecular Biology 132
  • Genetics 53
  • Public Health, Environmental and Occupational Health 51
  • Genetics 40
Replace Meike Fischer with:
Meike Fischer Germany
Magnus Tobiasson Sweden
Mara Molkentin Germany
Cécile K. Lopez France
Pierre Walrafen France
Catherine Hélias France
Yuichiro Semba Japan
Antonella Santoro United Kingdom
Manan Shah Australia
Andrea Inthal Austria
Panxiang Cao relative to Meike Fischer Germany Meike Fischer's profile →
Citations per field
00.5×
Meike Fischer · 1×
Citations per year

Countries citing papers authored by Panxiang Cao

Since Specialization
Citations

This map shows the geographic impact of Panxiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panxiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panxiang Cao more than expected).

Fields of papers citing papers by Panxiang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panxiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panxiang Cao. The network helps show where Panxiang Cao may publish in the future.

Co-authorship network of co-authors of Panxiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Panxiang Cao. A scholar is included among the top collaborators of Panxiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panxiang Cao. Panxiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 6
6 2
7 2
8 32
9 5
10 10
11 11
12 8
13 5
14 2
15 8
16 19
17 18
18 19
19 37
20 13

About Panxiang Cao

Panxiang Cao is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 255 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (12 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Hematology (160 citations), Genetics (53 citations) and Molecular Biology (132 citations). Panxiang Cao has collaborated with scholars based in China and United States. Frequent co-authors include Yang Zhang, Xue Chen, Hongxing Liu, Fang Wang, Xiaoli Ma, Mingyu Wang, Wen Teng, Yu Zhang, Jiaqi Chen and Jiancheng Fang. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026